Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022
Authors:
- Wieke Altorf-Van der KuilWKWieke Altorf-Van der Kuil
- Cornelia Ch WieldersCWCornelia Ch Wielders
- Romy D ZwittinkRZRomy D Zwittink
- Sabine C de GreeffSGSabine C de Greeff
- Dave A DongelmansDDDave A Dongelmans
- Ed J KuijperEKEd J Kuijper
- Daan W NotermansDNDaan W Notermans
- Annelot F SchoffelenASAnnelot F Schoffelen
Open Access
- 14 December 2023
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (50) , 2300152
Abstract
Background: The COVID-19 pandemic resulted in adaptation in infection control measures, increased patient transfer, high occupancy of intensive cares, downscaling of non-urgent medical procedures and decreased travelling.Aim: To gain insight in the influence of these changes on antimicrobial resistance (AMR) prevalence in the Netherlands, a country with a low AMR prevalence, we estimated changes in demographics and prevalence of six highly resistant microorganisms (HRMO) in hospitalised patients in the Netherlands during COVID-19 waves (March–June 2020, October 2020–June 2021, October 2021–May 2022 and June–August 2022) and interwaves (July–September 2020 and July–September 2021) compared with pre-COVID-19 (March 2019–February 2020).Methods: We investigated data on routine bacteriology cultures of hospitalised patients, obtained from 37 clinical microbiological laboratories participating in the national AMR surveillance. Demographic characteristics and HRMO prevalence were calculated as proportions and rates per 10,000 hospital admissions.Results: Although no significant persistent changes in HRMO prevalence were detected, some relevant non-significant patterns were recognised in intensive care units. Compared with pre-COVID-19 we found a tendency towards higher prevalence of meticillin-resistantStaphylococcus aureusduring waves and lower prevalence of multidrug-resistantPseudomonas aeruginosaduring interwaves. Additionally, during the first three waves, we observed significantly higher proportions and rates of cultures withEnterococcus faecium(pooled 10% vs 6% and 240 vs 120 per 10,000 admissions) and coagulase-negative Staphylococci (pooled 21% vs 14% and 500 vs 252 per 10,000 admissions) compared with pre-COVID-19.Conclusion: We observed no substantial changes in HRMO prevalence in hospitalised patients during the COVID-19 pandemic.Keywords
This publication has 31 references indexed in Scilit:
- Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemicJournal of Global Antimicrobial Resistance, 2021
- Antimicrobial resistance and COVID-19: Intersections and implicationseLife, 2021
- Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective StudyInternational Journal of Environmental Research and Public Health, 2021
- Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?Eurosurveillance, 2020
- Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemicCurrent Opinion in Critical Care, 2020
- [Clinical Characteristics of Coronavirus Disease 2019 in the Netherlands].2020
- National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the NetherlandsEurosurveillance, 2017
- Data Resource Profile: the Dutch National Intensive Care Evaluation (NICE) Registry of Admissions to Adult Intensive Care UnitsInternational Journal of Epidemiology, 2015
- Livestock-associated Methicillin-ResistantStaphylococcus aureusin Humans, the NetherlandsEmerging Infectious Diseases, 2012
- Epidemiological interpretation of antibiotic resistance studies – what are we missing?Nature Reviews Microbiology, 2004